Ensysce Biosciences (ENSC) Assets (2017 - 2025)
Ensysce Biosciences' Assets was $7.45 million in Q4 2025, up 33.1% from $5.6 million a year earlier and up 134.4% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Assets (2017 - 2025) Analysis & Trends
From Q4 2017 onward, Ensysce Biosciences has reported Assets for 33 quarters.
- Assets shows a five-year compound annual growth rate of 84.2% (FY2020 to FY2025).
- In earlier years, Assets was $5.6 million in FY2024 (+106.7%), $2.71 million in FY2023 (-54.0%), $5.89 million in FY2022 (-64.2%) and $16.42 million in FY2021.
- The Q4 2025 figure marks the highest quarterly Assets since Q3 2024.
- Compared with a year earlier, Assets was higher in five of the last eight quarters, with growth averaging 41.1%.
- The best year-over-year quarter for Assets over five years was Q3 2024 (growth of 191.6%); the worst was Q1 2021 (a decline of 78.9%).
- Per Business Quant data, ENSC's Assets in the three quarters before Q4 2025 was $3.18 million (Q3 2025), $5.57 million (Q2 2025) and $4.61 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Ensysce Biosciences | 901,219.67 | -10.35 Mn | - | 7.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.45 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 5.57 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 5.60 Mn |
| Sep 30, 2024 | 9.38 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 5.07 Mn |
| Dec 31, 2023 | 2.71 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 8.29 Mn |
| Jun 30, 2022 | 7.95 Mn |
| Mar 31, 2022 | 12.37 Mn |
| Dec 31, 2021 | 16.42 Mn |
| Sep 30, 2021 | 9.72 Mn |
| Jun 30, 2021 | 9.20 Mn |
| Mar 31, 2021 | 12.98 Mn |
API Access
Ensysce Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();